These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29161070)

  • 21. The Impact of Human Papillomavirus Catch-Up Vaccination in Australia: Implications for Introduction of Multiple Age Cohort Vaccination and Postvaccination Data Interpretation.
    Drolet M; Laprise JF; Brotherton JML; Donovan B; Fairley CK; Ali H; Bénard É; Martin D; Brisson M
    J Infect Dis; 2017 Dec; 216(10):1205-1209. PubMed ID: 28968800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of HPV vaccination on anogenital warts and respiratory papillomatosis.
    Wangu Z; Hsu KK
    Hum Vaccin Immunother; 2016 Jun; 12(6):1357-62. PubMed ID: 27217191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
    Perkins RB; Legler A; Hanchate A
    Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of anogenital warts in Germany: a population-based cohort study.
    Kraut AA; Schink T; Schulze-Rath R; Mikolajczyk RT; Garbe E
    BMC Infect Dis; 2010 Dec; 10():360. PubMed ID: 21182757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
    Park IU; Introcaso C; Dunne EF
    Clin Infect Dis; 2015 Dec; 61 Suppl 8():S849-55. PubMed ID: 26602622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence, Persistence, Clearance, and Correlates of Genital Human Papillomavirus Infection and Anogenital Warts in a Cohort of Men Living With Human Immunodeficiency Virus in South Africa.
    Chikandiwa A; Pisa PT; Muller EE; Tamalet C; Mayaud P; Chersich MF; Delany-Moretlwe S
    Sex Transm Dis; 2019 May; 46(5):347-353. PubMed ID: 30985636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada.
    Righolt CH; Willows K; Kliewer EV; Mahmud SM
    PLoS One; 2022; 17(4):e0267646. PubMed ID: 35472093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in the Prevalence of Anogenital Warts Among Patients at Sexually Transmitted Disease Clinics-Sexually Transmitted Disease Surveillance Network, United States, 2010-2016.
    Mann LM; Llata E; Flagg EW; Hong J; Asbel L; Carlos-Henderson J; Kerani RP; Kohn R; Pathela P; Schumacher C; Torrone EA
    J Infect Dis; 2019 Apr; 219(9):1389-1397. PubMed ID: 30500908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Papillomavirus Vaccination and Anogenital Warts: A Systematic Review of Impact and Effectiveness in the United States.
    Yakely AE; Avni-Singer L; Oliveira CR; Niccolai LM
    Sex Transm Dis; 2019 Apr; 46(4):213-220. PubMed ID: 30461595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promising control of genital warts: but is elimination possible?
    Lacey CJ; Garnett GP
    Lancet Infect Dis; 2011 Jan; 11(1):4-6. PubMed ID: 21183139
    [No Abstract]   [Full Text] [Related]  

  • 31. Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden.
    Herweijer E; Ploner A; Sparén P
    Vaccine; 2018 Apr; 36(15):1917-1920. PubMed ID: 29523448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts.
    Smith LM; Strumpf EC; Kaufman JS; Lofters A; Schwandt M; Lévesque LE
    Pediatrics; 2015 May; 135(5):e1131-40. PubMed ID: 25917991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing incidence of anogenital warts with an urban-rural divide among males in Manitoba, Canada, 1990-2011.
    Thompson LH; Nugent Z; Blanchard JF; Ens C; Yu BN
    BMC Public Health; 2016 Mar; 16():219. PubMed ID: 26939696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anogenital warts in Danish men who have sex with men.
    Skaaby S; Kofoed K
    Int J STD AIDS; 2011 Apr; 22(4):214-7. PubMed ID: 21515754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure.
    Lurie S; Mizrachi Y; Chodick G; Katz R; Schejter E
    Gynecol Oncol; 2017 Aug; 146(2):299-304. PubMed ID: 28602548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impacts of Human Papillomavirus Immunization Programs on Rates of Anogenital Warts in British Columbia, Canada, 2000 to 2017.
    Lukac CD; Donken R; Otterstatter M; Mazo O; Wong S; Marra F; Smith L; Naus M; Money D; Krajden M; Grennan T; Gilbert M; Wong J; Ogilvie GS
    Sex Transm Dis; 2020 Oct; 47(10):691-697. PubMed ID: 32649583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme.
    Chow EP; Read TR; Wigan R; Donovan B; Chen MY; Bradshaw CS; Fairley CK
    Sex Transm Infect; 2015 May; 91(3):214-9. PubMed ID: 25305210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of herd immunity from human papillomavirus vaccination.
    Bogaards JA; Berkhof J
    Lancet Infect Dis; 2011 Dec; 11(12):896; author reply 896-7. PubMed ID: 22115067
    [No Abstract]   [Full Text] [Related]  

  • 39. Early Evidence of the Effectiveness of the Human Papillomavirus Vaccination Program Against Anogenital Warts in Manitoba, Canada: A Registry Cohort Study.
    Willows K; Bozat-Emre S; Righolt CH; Kliewer EV; Mahmud SM
    Sex Transm Dis; 2018 Apr; 45(4):254-259. PubMed ID: 29465699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real world effectiveness of population-based roll out of human papillomavirus vaccination against rates of genital warts.
    Smith JS; Weiderpass E
    J Natl Cancer Inst; 2013 Apr; 105(7):449-51. PubMed ID: 23486549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.